You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alpelisib

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Characterize and Manage Hyperglycemia in Patients Initiating

Recruiting
  • Metastatic Breast Cancer
  • Alpelisib
  • FreeStyle Libre 2 Continuous Glucose Monitor
  • Saint Louis Park, Minnesota
    HealthPartners Cancer Research Center
Oct 16, 2023

Lymphatic Malformations Trial (Alpelisib, Placebo)

Not yet recruiting
  • Lymphatic Malformations
  • Alpelisib
  • Placebo
  • (no location specified)
Jul 4, 2023

Lymphangioma Trial in Albuquerque (Alpelisib)

Available
  • Lymphangioma
  • Alpelisib
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Alpelisib
  • +7 more
  • (no location specified)
Jul 28, 2023

Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Thalassery, Kerala, India
    Novartis Investigative Site
Nov 21, 2022

Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 30, 2023

PIK3CA-Related Overgrowth Spectrum (PROS) Trial in Worldwide (alpelisib)

Available
  • PIK3CA-Related Overgrowth Spectrum (PROS)
  • alpelisib
  • (no location specified)
Sep 9, 2022

Advanced Breast Cancer Trial in Orebro (Alpelisib, fulvestrant)

Terminated
  • Advanced Breast Cancer
  • Orebro, Sweden
  • +1 more
Nov 21, 2022

HR+, HER2-, Advanced Breast Cancer Trial (alpelisib)

Available
  • HR+, HER2-, Advanced Breast Cancer
  • alpelisib
  • (no location specified)
Jul 5, 2022

Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

Not yet recruiting
  • Breast Cancer Stage IV
  • Nice, France
  • +1 more
Nov 14, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting
  • Solid Tumors, Adult
  • +7 more
  • Alpelisib
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • (no location specified)
Aug 18, 2022

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer Trial in

Recruiting
  • Hormone Receptor Positive Breast Carcinoma
  • +2 more
  • Alpelisib
  • +2 more
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Alpelisib
  • +2 more
  • Aurora, Colorado
  • +2 more
Dec 29, 2022

Breast Tumors Trial in China (Alpelisib, Fulvestrant, Placebo)

Recruiting
  • Breast Neoplasms
  • Alpelisib
  • +2 more
  • Hefei, Anhui, China
  • +31 more
Dec 19, 2022

Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)

Active, not recruiting
  • Breast Cancer, PI3K, Alpelisib
  • Angers, France
  • +13 more
Mar 8, 2022

Breast Cancer Trial in United States (Alpelisib, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • Alpelisib
  • Sacituzumab govitecan
  • Fairway, Kansas
  • +6 more
Apr 4, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Alpelisib
  • +3 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

HNSCC Trial in United States (Tipifarnib, Alpelisib)

Recruiting
  • HNSCC
  • Duarte, California
  • +10 more
Jun 30, 2022

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Solid Tumor, Stomach Cancer Trial in Seongnam-si, Seoul (Alpelisib, Paclitaxel)

Recruiting
  • Solid Tumor
  • Stomach Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Aug 21, 2021